Clinical research study on pre-natal supplementation reducing the risk of asthma using Incromega™ TG3322

摘要

Croda's Incromega™ TG3322 fish oil concentrate has recently been featured in a study undertaken at The University of Copenhagen. The study explored the reduction in the risk of asthma developing in children after birth, with those mothers taking the fish oil supplement during pregnancy. The study was undertaken at Copenhagen University, within their clinical research unit for pediatric asthma research. The fish oil concentrate used in the study was Croda's IncromegaTM TG3322.